switching between glp-1 agonists ada Glucagon-like peptide-1 receptor: mechanisms and advances in therapy Frontiers | Clinical perspectives on

This is your opportunity to ask questions and understand every aspect of your weight loss goals and treatment journey

Direct cardiovascular effects of glucagon like peptide-1

Obesity (Silver Spring, Md) 2014;22(1):513

Now considered a landmark in the GLP-1 field, the article listed Mojsov as the first author and Habener as the last, a position customarily reserved for the senior author (Couzin-Frankel 8 Sept 2023

Second, this analysis focused exclusively on a subset of GLP-1 RA therapies (specifically semaglutide and tirzepatide) and did not account for other common PCOS treatments, such as metformin, combined oral contraceptives, or anti-androgen therapies

For a completely different side effect profile, consider bupropion-naltrexone (Contrave)